- Home
- GYRE vs CCEC Comparison
GYRE vs CCEC Comparison
Compare GYRE & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- CCEC
- Stock Information
- Founded
- GYRE 2002
- CCEC 2007
- Country
- GYRE United States
- CCEC Greece
- Employees
- GYRE N/A
- CCEC N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- CCEC Marine Transportation
- Sector
- GYRE Health Care
- CCEC Consumer Discretionary
- Exchange
- GYRE Nasdaq
- CCEC Nasdaq
- Market Cap
- GYRE 997.3M
- CCEC 1.1B
- IPO Year
- GYRE N/A
- CCEC 2007
- Fundamental
- Price
- GYRE $11.54
- CCEC $18.50
- Analyst Decision
- GYRE
- CCEC Buy
- Analyst Count
- GYRE 0
- CCEC 2
- Target Price
- GYRE N/A
- CCEC $24.00
- AVG Volume (30 Days)
- GYRE 53.5K
- CCEC 14.3K
- Earning Date
- GYRE 03-25-2025
- CCEC 02-06-2025
- Dividend Yield
- GYRE N/A
- CCEC 3.31%
- EPS Growth
- GYRE N/A
- CCEC 20.78
- EPS
- GYRE N/A
- CCEC 2.60
- Revenue
- GYRE $105,033,000.00
- CCEC $369,413,000.00
- Revenue This Year
- GYRE $25.32
- CCEC $19.92
- Revenue Next Year
- GYRE $12.95
- CCEC $22.58
- P/E Ratio
- GYRE N/A
- CCEC $149.01
- Revenue Growth
- GYRE N/A
- CCEC 2.45
- 52 Week Low
- GYRE $8.26
- CCEC $14.45
- 52 Week High
- GYRE $26.37
- CCEC $20.26
- Technical
- Relative Strength Index (RSI)
- GYRE 47.99
- CCEC N/A
- Support Level
- GYRE $12.09
- CCEC N/A
- Resistance Level
- GYRE $12.80
- CCEC N/A
- Average True Range (ATR)
- GYRE 0.56
- CCEC 0.00
- MACD
- GYRE -0.00
- CCEC 0.00
- Stochastic Oscillator
- GYRE 16.39
- CCEC 0.00
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.